Abstract
Restriction analysis of the NAT2 gene was carried out in inhabitants of Novosibirsk. Polymorphism of this gene for nine known point mutations was studied in a sample of Novosibirsk residents consisting of 109 healthy Caucasians. The frequencies of these mutations did not significantly differ from the frequencies reported for Caucasian populations of other countries. In 79 patients with lung cancer, a region of the NAT2 gene that includes 29.7% of the coding sequence was analyzed for the new mutations by the RFLP analysis. No new mutations were found in this group.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Hein, D.W., Doll, M.A., Fretland, A.J., et al., Molecular Genetics and Epidemiology of the NAT1 and NAT2 Acetylation Polymorphisms, Cancer Epidemiol. Biom-arkers Prev., 2000, vol. 9, pp. 29–42.
Hickman, D. and Sim, E., N-Acetyltransferase Polymor-phism: Comparison of Phenotype and Genotype in Human, Biochem. Pharmacol., 1991, vol. 42, pp. 1007–1014.
Hickman, D., Risch, A., Buckle, V., et al., Chromosomal Localization of Human Genes for Arylamine N-Acetyl-transferase, Biochem. J., 1994, vol. 297, pp. 441–445.
Hein, D.W., Grant, D.M., and Sim, E., Update on Con-sensus Arylamine N-Acetyltransferases Nomenclature, Pharmacogenetics, 2000, vol. 10, pp. 291–292.
Meyer, U.A. and Zanger, U.M., Molecular Mechanisms of Genetic Polymorphisms of Drug Metabolism, Annu. Rev. Pharmacol. Toxicol., 1997, vol. 37, pp. 269–296.
Hein, D.W., N-Acetyltransferase Genetics and Their Role in Predisposition to Aromatic and Heterocyclic Amine-Induced Carcinogenesis, Toxicol. Lett., 2000, vol. 15, pp. 349–356.
Leff, M.A., Fretland, A.J., Doll, M.A., and Hein, D.W., Novel Human N-Acetyltransferase-2 Alleles That Differ in Mechanism for Slow Acetylator Phenotype, J. Biol. Chem., 1999, vol. 274, pp. 34 519–34 522.
Fretland, A.J., Leff, M.A., Doll, M.A., and Hein, D.W., Functional Characterization of Human N-Acetyltrans-ferase 2 (NAT2) Single Nucleotide Polymorphisms, Pharmacogenetics, 2001, vol. 11, pp. 207–215.
Hickman, D., Palamanda, J.R., Unadkat, J.D., and Sim, E., Enzyme Kinetic Properties of Human N-Acetyltrans-ferase 2 Allotypic Variants Expressed in Escherichia coli, Biochem. Pharmacol., 1995, vol. 50, pp. 697–703.
Kunkel, L.M., Smith, K.D., Boyer, S.H., et al., Analysis of Human Y-Chromosome-Specific Reiterated DNA in Chromosome Variants, Proc. Natl. Acad. Sci. USA, 1977, vol. 74, pp. 1245–1249.
Woolhouse, N.M., Qureshi, M.M., and Bayoumi, R.A.L., A New Mutation C759T in the Polymorphic N-Acetyl-transferase (NAT2) Gene, Pharmacogenetics, 1997, vol. 7, pp. 83–84.
Hickman, D., Risch, A., Camilleri, J.P., and Sim, E., Genotyping Human Polymorphic Arylamine N-Acetyl-transferase: Identification of New Slow Allotypic Vari-ants, Pharmacogenetics, 1992, vol. 2, pp. 217–226.
Bell, D.A., Taylor, J.A., Butler, M.A., et al., Geno-type/ Phenotype Discordance for Human Arylamine N-Acetyltransferase (NAT2) Reveals a New Slow-Acetyla-tor Allele Common in African-Americans, Carcinogen-esis, 1993, vol. 14, pp. 1689–1692.
Viktorova, T.V., Korytina, G.F., Makarova, O.V., et al., Polymorphism of the Arylamine N-Acetyltransferase 2 Gene in Ethnic Populations of the Volga–Ural Region, Mol. Biol. (Moscow), 2003, vol. 37, pp. 971–974.
Gaikovitch, E.A., Cascorbi, I., Mrozikiewicz, P.M., et al., Polymorphisms of Drug-Metabolizing Enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-Glycoprotein in a Russian Population, Eur. J. Clin. Pharmacol., 2003, vol. 59, pp. 303–312.
Gross, M., Kruisselbrink, T., Anderson, K., et al., Distri-bution and Concordance of N-Acetyltransferase Geno-type and Phenotype in an American Population, Cancer Epidemiol. Biomarkers Prev., 1999, vol. 8, pp. 683–692.
Brockmoller, J., Cascorbi, I., Kerb, R., and Roots, I., Combined Analysis of Inherited Polymorphisms in Ary-lamine N-Acetyltransferase 2, Glutathione S-Trans-ferase M1 and T1, Microsomal Epoxide Hydrolase, and Cytochrome P450 Enzymes as Modulators of Bladder Cancer Risk, Cancer Res., 1996, vol. 56, pp. 3915–3925.
Lyakhovich, V.V., Vavilin, V.A., Gutkina, N.I., et al., Genes and Enzymes of the Xenobiotic Metabolism Sys-tem in Cancer, Vopr. Med. Khim., 1997, vol. 5, pp. 330–338.
Vatsis, K.P., Weber, W.W., Bell, D.A., et al., Nomencla-ture for N-Acetyltransferases, Pharmacogenetics, 1995, vol. 5, pp. 1–17.
Anitha, A. and Banerjee, M., Arylamine N-Acetyltrans-ferase 2 Polymorphism in the Ethnic Populations of South India, Int. J. Mol. Med., 2003, vol. 11, pp. 125–131.
Rodrigues-Lima, F. and Dupret, J.-M., 3D Model of Human Arylamine N-Acetyltransferase 2: Structural Basis of the Slow Acetylator Phenotype of the R64Q Variant and Analysis of the Active-Site Loop, Biochem. Biophys. Res. Commun., 2002, vol. 291, pp. 116–123.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nikishina, M.V., Makarova, S.I., Akishev, A.G. et al. Restriction Analysis of N-Acetyltransferase 2 Gene in Caucasian Population of West Siberia. Russian Journal of Genetics 40, 1288–1291 (2004). https://doi.org/10.1023/B:RUGE.0000048672.78131.8e
Issue Date:
DOI: https://doi.org/10.1023/B:RUGE.0000048672.78131.8e